CLC Bio Partners with South Africa's Inqaba on TB Sequencing Study | GenomeWeb
NEW YORK (GenomeWeb News) - CLC Bio is partnering with Inqaba Biotechnical Industries, a genomic services firm based in Pretoria, South Africa, to sequence, assemble, and analyze data from multiple strains of Mycobacterium tuberculosis, the bioinformatics firm said last week.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.